Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2018-09-05 | Reverse | 1:15 |
| 2016-11-29 | Reverse | 1:9 |
| 2016-05-09 | Reverse | 1:12 |
| 2011-07-06 | Reverse | 1:10 |
Microbot Medical Inc. develops robotic endoluminal devices for minimally invasive surgery, including treatments for hydrocephalus and endovascular procedures, with patented technologies and a collaboration with Stryker.

The LIBERTY® Endovascular Robotic System, FDA-cleared and single-use, enables remote, precise navigation of vascular tools, reducing radiation and strain, with full market launch planned for April 2026 by Microbot Medical.
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
OVID | $2.80 | COMPARE |
RCEL | $10.35 | COMPARE |
CRDL | $1.94 | COMPARE |
ORMP | $5.03 | COMPARE |
VANI | $1.42 | COMPARE |
ZTEK | $0.54 | COMPARE |
CLNN | $4.23 | COMPARE |
NSPR | $0.85 | COMPARE |